The Future of Ketamine and Temper Disorders In 2019, the FDA and European Commission approved the usage of an esketamine nasal spready underneath the brand name name Spravato to treat melancholy. Even so, as of 2021, ketamine has not been permitted through the FDA to deal with despair or other psychological health disorders, and therefore, the medi